ATE175978T1 - Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität - Google Patents

Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität

Info

Publication number
ATE175978T1
ATE175978T1 AT93919457T AT93919457T ATE175978T1 AT E175978 T1 ATE175978 T1 AT E175978T1 AT 93919457 T AT93919457 T AT 93919457T AT 93919457 T AT93919457 T AT 93919457T AT E175978 T1 ATE175978 T1 AT E175978T1
Authority
AT
Austria
Prior art keywords
activity
igf
specific molecules
increase igf
antibodies
Prior art date
Application number
AT93919457T
Other languages
English (en)
Inventor
Jennifer Margaret Pell
Peter Charles Bates
Claire Elisabeth Hamil Stewart
Original Assignee
Biotech & Biolog Scien Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech & Biolog Scien Res filed Critical Biotech & Biolog Scien Res
Application granted granted Critical
Publication of ATE175978T1 publication Critical patent/ATE175978T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93919457T 1992-08-20 1993-08-20 Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität ATE175978T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217696A GB9217696D0 (en) 1992-08-20 1992-08-20 Use of specific binding molecules

Publications (1)

Publication Number Publication Date
ATE175978T1 true ATE175978T1 (de) 1999-02-15

Family

ID=10720662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93919457T ATE175978T1 (de) 1992-08-20 1993-08-20 Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität

Country Status (8)

Country Link
EP (1) EP0656908B1 (de)
AT (1) ATE175978T1 (de)
AU (1) AU674697B2 (de)
CA (1) CA2141861A1 (de)
DE (1) DE69323204D1 (de)
GB (1) GB9217696D0 (de)
NZ (1) NZ255461A (de)
WO (1) WO1994004569A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501472D0 (sv) * 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
JP2002535967A (ja) 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
US6040292A (en) * 1999-06-04 2000-03-21 Celtrix Pharmaceuticals, Inc. Methods for treating diabetes
CA2402191C (en) 2000-03-24 2012-03-13 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
WO2001087323A2 (en) 2000-05-16 2001-11-22 Genentech, Inc. Method for treating cartilage disorders
IL156435A0 (en) 2001-02-09 2004-01-04 Genentech Inc Crystallization of igf-1
US7071300B2 (en) 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
WO2004039845A1 (en) * 2002-10-31 2004-05-13 Universita'degli Studi Di Roma 'la Sapienza' Antimicrobial lipase antibodies their nucleotide and aminoacid sequences and uses thereof
DK2274978T3 (en) 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Methods of treating an insulin-like growth factor-I (IGF-I) deficiency
EP1676862B1 (de) * 2003-09-24 2010-12-22 Kyowa Hakko Kirin Co., Ltd. Rekombinanter antikörper gegen humanen insulin-like growth factor
JP2008513372A (ja) 2004-09-13 2008-05-01 アロースミス テクノロジーズ エルエルピー インビボでのリガンドの抗体緩衝
EP1988920A1 (de) 2006-02-02 2008-11-12 Rinat Neuroscience Corp. Verfahren zur behandlung von fettsucht durch verabreichung eines trkb-antagonisten
KR100861914B1 (ko) * 2006-03-06 2008-10-09 (주)케어젠 인슐린 유사 성장인자―１의 활성을 가지는 펩타이드 및그의 용도
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
KR101669140B1 (ko) 2015-04-28 2016-10-26 (주)케어젠 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도
US20210008172A1 (en) 2019-07-11 2021-01-14 Opko Biologics Ltd. Long-acting igf-1 or igf-1 variants and methods of producing same

Also Published As

Publication number Publication date
EP0656908A1 (de) 1995-06-14
DE69323204D1 (de) 1999-03-04
AU4967393A (en) 1994-03-15
WO1994004569A1 (en) 1994-03-03
NZ255461A (en) 1996-12-20
CA2141861A1 (en) 1994-03-03
AU674697B2 (en) 1997-01-09
GB9217696D0 (en) 1992-09-30
EP0656908B1 (de) 1999-01-20

Similar Documents

Publication Publication Date Title
ATE175978T1 (de) Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität
ATE207520T1 (de) Durch aldehyd geharteterklebstoff auf basis von protein
DE68916537D1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
DE69423911D1 (de) Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
ATE250426T1 (de) Verwendung von verbindungen die an ein zytoplasmatischen dipeptidase binden zur potenzierung des immunantworts
DE68903985D1 (de) Behaelter fuer den transport von transplantaten.
ATE77937T1 (de) Kosmetisches praeparat.
ATE238802T1 (de) Zusammensetzung von glibenclamid und metformine zur behandlung von diabetes mellitis typ ii
DE69316948D1 (de) Lösliche Liganden für CD40
ATE161730T1 (de) Antikörper zur behandlung von insulinabhängigen diabetes
DE69033735D1 (de) Varianten von adhäsionsmoleküle für blutplättchen
DE69309472D1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
PT92278A (pt) Processo para a preparacao de proteinas de ligacao de factor de crescimento semelhante a insulina
DE59009034D1 (de) Desodorierende kosmetische mittel.
NO904023D0 (no) Blanding som induserer binding.
DE68915494D1 (de) Zubereitung mit verzögerter freigabe durch verwendung von alginaten.
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
ZA917669B (en) Antagonists of human gamma interferon
CA2008817A1 (en) M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
ATE205188T1 (de) Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus
Heatwole The concept of the econe, a fundamental ecological unit.
GB9101183D0 (en) Depot formulations
RU95107066A (ru) Композиционный гуминокремнеземный сорбент